Lab21 Acquires Biotec Laboratories
March 3, 2009
Lab21 Ltd has today announced that it has purchased the majority shareholding of Biotec Laboratories Ltd, a clinical diagnostic company with particular emphasis on infectious diseases, most notably tuberculosis (TB). As part of the sale, Lab21 also acquires Biotec’s South African subsidiary, Biotec Laboratories SA which is a joint venture with the Cape Biotech Trust. [...]
March 3, 2009
Ann Arbor, MICHIGAN, 03 March 2009 - NextGen Sciences, the provider of biomarker discovery, assay development and testing services, has sold its electrophoresis business to Sigma-Aldrich Corporation. NextGen Sciences will receive a cash payment and royalty payments on revenues for three years. This announcement follows on from the divestiture of the non core ‘gene to [...]
March 3, 2009
Complete Genomics Inc., a recently launched, third-generation human genome sequencing company, today announced a collaboration with the Broad Institute of MIT and Harvard to conduct complete human genome sequencing pilot studies of two cancers — glioblastoma and melanoma. Complete Genomics will use its proprietary DNA sequencing technology to sequence five genomes from samples provided by [...]
March 3, 2009
ST. LOUIS, March 3 -- Sigma-Aldrich (Nasdaq: SIAL) today announced the global release of the MISSION(R) LentiPlex(TM) Pooled Human and Murine shRNA Libraries (https://www.sigma-aldrich.com/lentiplex). Using the shRNA collections of The RNAi Consortium (TRC), the MISSION LentiPlex Pooled shRNA Libraries enable rapid, genome-wide RNAi screening at the bench-top level in a convenient and powerful, pooled lentiviral [...]
Sequenom Selects PDI to Provide Sales Team for Launch of Noninvasive Prenatal Screening Tests
March 3, 2009
SADDLE RIVER, N.J. & SAN DIEGO--PDI, Inc. (NASDAQ:PDII), and Sequenom Center for Molecular Medicine, LLC (SCMM), a wholly owned subsidiary of Sequenom, Inc. (NASDAQ:SQNM) announced today that PDI has been selected to provide the sales infrastructure to launch and commercialize SCMM’s noninvasive prenatal genetic screening tests based on its SEQureDx™ technology. Under the direction of [...]
HP and Partners HealthCare Extend Collaboration in Support of Personalized Medicine
March 3, 2009
Integration of IT and healthcare advanced through multi-year agreement HP and Partners HealthCare today announced the extension of a successful five-year, multi-million dollar agreement to develop software and implement hardware and services supporting Partners’ efforts to accelerate clinical genomics and advance personalized medicine. This phase of the collaboration focuses on extending Partners’ technology infrastructure, especially [...]
Fluidigm Sells Record Numbers of Systems and IFC Chips in 2008 College & University Pressroom
March 3, 2009
SOUTH SAN FRANCISCO, Calif.--Fluidigm announced that its instrument and integrated fluidic circuit (IFC) sales reached record levels in 2008. Volumes of both BioMark™ instruments and Fluidigm chips more than doubled when compared to 2007. “In the first half of 2008 we basically matched our prior year’s level of product sales. In the second half our [...]
Seegene Introduces Highly Sensitive Multiplex Tuberculosis Detection
March 3, 2009
Improved TB Testing With Seeplex(R) MTB ACE Detection Promises to Help Eradicate a Disease Threatening Public Health Worldwide ROCKVILLE, MD - Early detection and treatment of tuberculosis (TB) is an international health care priority, as rapidly migrating populations in a globalized economy ensure the continuation of this highly treatable disease. TB is highly contagious and [...]
March 3, 2009
New innovation to help enable semiconductor and pharmaceutical industries to evaluate and influence vital ultra-small structures RESEARCH TRIANGLE PARK, N.C.--Just as x-ray technology, MRI and sonography transformed the practice of medicine, a newly created approach for seeing the invisible promises great potential for finding new ways to improve the health of human and microelectronic patients [...]
Agilent Technologies Introduces Next-Generation Microarrays, Quadrupling Probe Density
March 3, 2009
SANTA CLARA, Calif.--Agilent Technologies Inc. (NYSE:A - News) today announced the introduction of its SurePrint G3 Microarrays. These third-generation Agilent microarrays contain up to one million probes on a standard 1in. x 3 in. glass slide. Initial applications are array-based comparative genomic hybridization (aCGH) and copy number variation (CNV), with other applications to follow. Source: [...]
